Exon skip ID | chr | Exons involved in exon skipping | Skipped exon |
exon_skip_103408 | chr6 | 33441743:33441759:33442453:33442494:33442889:33442973 | 33442453:33442494 |
exon_skip_119954 | chr6 | 33441711:33441759:33442453:33442494:33442889:33442973 | 33442453:33442494 |
exon_skip_147772 | chr6 | 33447843:33447933:33448789:33448868:33451760:33451831 | 33448789:33448868 |
exon_skip_153650 | chr6 | 33447843:33447933:33448789:33448868:33451760:33451799 | 33448789:33448868 |
exon_skip_161870 | chr6 | 33438775:33438919:33440553:33440965:33441173:33441374 | 33440553:33440965 |
exon_skip_203326 | chr6 | 33441581:33441759:33442453:33442494:33442889:33442973 | 33442453:33442494 |
exon_skip_253443 | chr6 | 33438775:33438919:33440729:33440965:33441173:33441374 | 33440729:33440965 |
exon_skip_264050 | chr6 | 33432685:33432806:33435152:33435305:33435515:33435613 | 33435152:33435305 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q96PV0 | 559 | 637 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 559 | 637 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 559 | 637 | 443 | 635 | Domain | Note=Ras-GAP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00167 |
Q96PV0 | 559 | 637 | 443 | 635 | Domain | Note=Ras-GAP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00167 |
Q96PV0 | 559 | 637 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 562 | 562 | Natural variant | ID=VAR_069233;Note=In MRD5%3B the disease phenotype consists of intellectual disability and autism%3B the mutant protein is less efficient in inhibiting ERK phosphorylation induced by neuronal activity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269| |
Q96PV0 | 559 | 637 | 562 | 562 | Natural variant | ID=VAR_069233;Note=In MRD5%3B the disease phenotype consists of intellectual disability and autism%3B the mutant protein is less efficient in inhibiting ERK phosphorylation induced by neuronal activity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269| |
Q96PV0 | 765 | 778 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 765 | 778 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 765 | 778 | 766 | 766 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QUH6 |
Q96PV0 | 765 | 778 | 766 | 766 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QUH6 |
Q96PV0 | 765 | 778 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 701 | 1343 | Natural variant | ID=VAR_078618;Note=In MRD5%3B moderate%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 701 | 1343 | Natural variant | ID=VAR_078618;Note=In MRD5%3B moderate%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q96PV0 | 765 | 778 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 765 | 778 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 765 | 778 | 766 | 766 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QUH6 |
Q96PV0 | 765 | 778 | 766 | 766 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QUH6 |
Q96PV0 | 765 | 778 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 701 | 1343 | Natural variant | ID=VAR_078618;Note=In MRD5%3B moderate%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 701 | 1343 | Natural variant | ID=VAR_078618;Note=In MRD5%3B moderate%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q96PV0 | 559 | 637 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 559 | 637 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 559 | 637 | 443 | 635 | Domain | Note=Ras-GAP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00167 |
Q96PV0 | 559 | 637 | 443 | 635 | Domain | Note=Ras-GAP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00167 |
Q96PV0 | 559 | 637 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 559 | 637 | 562 | 562 | Natural variant | ID=VAR_069233;Note=In MRD5%3B the disease phenotype consists of intellectual disability and autism%3B the mutant protein is less efficient in inhibiting ERK phosphorylation induced by neuronal activity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269| |
Q96PV0 | 559 | 637 | 562 | 562 | Natural variant | ID=VAR_069233;Note=In MRD5%3B the disease phenotype consists of intellectual disability and autism%3B the mutant protein is less efficient in inhibiting ERK phosphorylation induced by neuronal activity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269| |
Q96PV0 | 765 | 778 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 765 | 778 | 1 | 1343 | Chain | ID=PRO_0000056654;Note=Ras/Rap GTPase-activating protein SynGAP |
Q96PV0 | 765 | 778 | 766 | 766 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QUH6 |
Q96PV0 | 765 | 778 | 766 | 766 | Modified residue | Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9QUH6 |
Q96PV0 | 765 | 778 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 143 | 1343 | Natural variant | ID=VAR_078616;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 267 | 1343 | Natural variant | ID=VAR_078617;Note=In MRD5%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 701 | 1343 | Natural variant | ID=VAR_078618;Note=In MRD5%3B moderate%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |
Q96PV0 | 765 | 778 | 701 | 1343 | Natural variant | ID=VAR_078618;Note=In MRD5%3B moderate%3B associated with autistic spectrum disorder and epileptic encephalopathy. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23708187;Dbxref=PMID:23708187 |